You may have heard the word psychobiotics, a catchy label for probiotics, prebiotics, and similar interventions studied specifically for mental wellbeing. The encouraging news is that this is one of the better-supported corners of the field. A systematic review of randomized controlled trials run between 2000 and 2023, spanning 51 studies and 3,353 participants, found that psychobiotic approaches showed notable effectiveness, particularly for depressive symptoms, as reported in the journal Nutrients.
A separate meta-analysis in BMC Psychiatry pooled 23 trials with 1,401 participants, eighteen focused on depression and nine on anxiety, and likewise found these interventions associated with symptom improvements compared with control groups. Across this research, a few patterns stand out:
- The most commonly studied microbes come from the Lactobacillus and Bifidobacterium families.
- Study periods usually ran from about 4 to 24 weeks.
- Specific strains showing benefit in trials include Lacticaseibacillus casei Shirota, Lactobacillus gasseri CP2305, Lactiplantibacillus plantarum PS128, Lacticaseibacillus rhamnosus LR06, and Bifidobacterium longum.
Two important caveats keep this grounded. Benefits appeared under controlled trial conditions and describe symptom improvement, not a cure, and researchers repeatedly stress that trials vary so widely in strains, doses, and participants that larger, longer studies are still needed. If you want a fuller primer, our explainer on what psychobiotics are walks through the basics.